Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2004 4
2005 2
2008 3
2009 1
2010 5
2011 6
2012 5
2013 5
2014 3
2015 3
2016 8
2017 5
2018 5
2019 3
2020 5
2021 6
2022 10
2023 12
2024 16
2025 11

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

113 results

Results by year

Filters applied: . Clear all
Page 1
Mobilise-D insights to estimate real-world walking speed in multiple conditions with a wearable device.
Kirk C, Küderle A, Micó-Amigo ME, Bonci T, Paraschiv-Ionescu A, Ullrich M, Soltani A, Gazit E, Salis F, Alcock L, Aminian K, Becker C, Bertuletti S, Brown P, Buckley E, Cantu A, Carsin AE, Caruso M, Caulfield B, Cereatti A, Chiari L, D'Ascanio I, Garcia-Aymerich J, Hansen C, Hausdorff JM, Hiden H, Hume E, Keogh A, Kluge F, Koch S, Maetzler W, Megaritis D, Mueller A, Niessen M, Palmerini L, Schwickert L, Scott K, Sharrack B, Sillén H, Singleton D, Vereijken B, Vogiatzis I, Yarnall AJ, Rochester L, Mazzà C, Eskofier BM, Del Din S; Mobilise-D consortium. Kirk C, et al. Sci Rep. 2024 Jan 19;14(1):1754. doi: 10.1038/s41598-024-51766-5. Sci Rep. 2024. PMID: 38243008 Free PMC article.
Mobile health applications in cardiovascular research.
Sarwar CMS, Vaduganathan M, Anker SD, Coiro S, Papadimitriou L, Saltz J, Schoenfeld ER, Clark RL, Dinh W, Kramer F, Gheorghiade M, Fonarow GC, Butler J. Sarwar CMS, et al. Among authors: kramer f. Int J Cardiol. 2018 Oct 15;269:265-271. doi: 10.1016/j.ijcard.2018.06.039. Epub 2018 Jun 12. Int J Cardiol. 2018. PMID: 29921516 Review.
Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum: an individual participant data analysis of the VICTORIA and VICTOR trials.
Zannad F, O'Connor CM, Butler J, McMullan CJ, Anstrom KJ, Barash I, Bonaca MP, Borentain M, Corda S, Gates D, Ezekowitz JA, Hernandez AF, Lam CSP, Lewis EF, Lindenfeld J, Mentz RJ, Ponikowski P, Reddy YNV, Rosano GMC, Saldarriaga C, Senni M, Teixeira PP, Udelson J, Urbinati A, Vlajnic V, Voors AA, Xing A, Patel MJ, Armstrong PW; VICTORIA and VICTOR Study Groups. Zannad F, et al. Lancet. 2025 Sep 27;406(10510):1351-1362. doi: 10.1016/S0140-6736(25)01682-4. Epub 2025 Aug 30. Lancet. 2025. PMID: 40897188 Free article. Clinical Trial.
Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): randomised, double-blind, placebo-controlled multicentre trial.
Khanna D, Allanore Y, Denton CP, Kuwana M, Matucci-Cerinic M, Pope JE, Atsumi T, Bečvář R, Czirják L, Hachulla E, Ishii T, Ishikawa O, Johnson SR, De Langhe E, Stagnaro C, Riccieri V, Schiopu E, Silver RM, Smith V, Steen V, Stevens W, Szücs G, Truchetet ME, Wosnitza M, Laapas K, de Oliveira Pena J, Yao Z, Kramer F, Distler O. Khanna D, et al. Among authors: kramer f. Ann Rheum Dis. 2020 May;79(5):618-625. doi: 10.1136/annrheumdis-2019-216823. Ann Rheum Dis. 2020. PMID: 32299845 Free PMC article. Clinical Trial.
Working with Ontologies.
Kramer F, Beißbarth T. Kramer F, et al. Methods Mol Biol. 2017;1525:123-135. doi: 10.1007/978-1-4939-6622-6_6. Methods Mol Biol. 2017. PMID: 27896720
Biomarker analysis from the phase 2b randomized placebo-controlled trial of riociguat in early diffuse cutaneous systemic sclerosis.
Khanna D, Kramer F, Höfler J, Ghadessi M, Sandner P, Allanore Y, Denton CP, Kuwana M, Matucci-Cerinic M, Pope JE, Atsumi T, Bečvář R, Czirják L, De Langhe E, Hachulla E, Ishii T, Ishikawa O, Johnson SR, Riccieri V, Schiopu E, Silver RM, Smith V, Stagnaro C, Steen V, Stevens W, Szücs G, Truchetet ME, Wosnitza M, Distler O. Khanna D, et al. Among authors: kramer f. Rheumatology (Oxford). 2024 Nov 1;63(11):3124-3134. doi: 10.1093/rheumatology/keae150. Rheumatology (Oxford). 2024. PMID: 38460548 Free PMC article. Clinical Trial.
RFMiD: Retinal Image Analysis for multi-Disease Detection challenge.
Pachade S, Porwal P, Kokare M, Deshmukh G, Sahasrabuddhe V, Luo Z, Han F, Sun Z, Qihan L, Kamata SI, Ho E, Wang E, Sivajohan A, Youn S, Lane K, Chun J, Wang X, Gu Y, Lu S, Oh YT, Park H, Lee CY, Yeh H, Cheng KW, Wang H, Ye J, He J, Gu L, Müller D, Soto-Rey I, Kramer F, Arai H, Ochi Y, Okada T, Giancardo L, Quellec G, Mériaudeau F. Pachade S, et al. Among authors: kramer f. Med Image Anal. 2025 Jan;99:103365. doi: 10.1016/j.media.2024.103365. Epub 2024 Oct 9. Med Image Anal. 2025. PMID: 39395210
DrNote: An open medical annotation service.
Frei J, Soto-Rey I, Kramer F. Frei J, et al. Among authors: kramer f. PLOS Digit Health. 2022 Aug 15;1(8):e0000086. doi: 10.1371/journal.pdig.0000086. eCollection 2022 Aug. PLOS Digit Health. 2022. PMID: 36812581 Free PMC article.
Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): open-label, long-term extension of a phase 2b, randomised, placebo-controlled trial.
Distler O, Allanore Y, Denton CP, Kuwana M, Matucci-Cerinic M, Pope JE, Atsumi T, Bečvář R, Czirják L, Hachulla E, Ishii T, Ishikawa O, Johnson SR, De Langhe E, Stagnaro C, Riccieri V, Schiopu E, Silver RM, Smith V, Steen V, Stevens W, Szücs G, Truchetet ME, Wosnitza M, Laapas K, Kramer F, Khanna D. Distler O, et al. Among authors: kramer f. Lancet Rheumatol. 2023 Nov;5(11):e660-e669. doi: 10.1016/S2665-9913(23)00238-2. Lancet Rheumatol. 2023. PMID: 38251533 Clinical Trial.
113 results